On January 7, 2020 ImmunityBio, a privately held immunotherapy company focused on developing a T-cell memory cancer vaccine, reported that Patrick Soon-Shiong, M.D., Chairman and Chief Executive Officer, will present at the 38th Annual J.P. Morgan Healthcare Conference on Tuesday, January 14, 2020 at 11:00 a.m. Pacific Time (Press release, ImmunityBio, JAN 7, 2020, View Source [SID1234552803]). The event will be held at the Westin St. Francis in San Francisco.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Dr. Soon-Shiong will present clinical updates and the registration strategy of the combination therapy of NantKwest’s off-the-shelf NK therapy with ImmunityBio’s N-803 molecule, as well as discuss the future relationship between the two companies’ immunotherapy platforms.

A live audio webcast of the conference presentation will be available on the ImmunityBio and NantKwest websites, immunitybio.com and NantKwest.com. An archived replay will be available on the websites for approximately 30 days.